Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001967221 | SCV002201085 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblF | 2021-04-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). This variant has not been reported in the literature in individuals with LMBRD1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with serine at codon 444 of the LMBRD1 protein (p.Leu444Ser). The leucine residue is highly conserved and there is a large physicochemical difference between leucine and serine. |
Fulgent Genetics, |
RCV001967221 | SCV002790299 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblF | 2021-09-15 | criteria provided, single submitter | clinical testing |